30.11.2022 • News

Invista Breaks Ground on US Nylon Expansion

To help supply the expanding global demand for PA 6.6, which it markets as Nylon, US-based trademark owner Invista, now part of Koch Industries, is building a new plant at its Camden, South Carolina, production site, where groundbreaking ceremonies were recently held.

The company that continues the legacy of the polyamide brand invented by DuPont, said it plans to spend around $64 million over the next two years to enhance the South Carolina site’s polymer and fiber spinning production. This will add nine loading docks, 22 storage/packaging silos and bulk loading capabilities.

Without quantifying the expected capacity gain beyond the estimated 250,000 t/y it currently produces at Camden, Invista said the new facility will allow it to “increase the production volume of polymer to new markets, deliver newly developed polymers, implement future volume expansion opportunities and have the flexibility to meet customers’ individual packaging needs.” 

The company is partnering with Katoen Natie Specialty Chemicals USA on the project due to be completed in 2024.

Author: Dede Williams, Freelance Journalist

The Invista nylon site in South Carolina hosted a groundbreaking ceremony for...
The Invista nylon site in South Carolina hosted a groundbreaking ceremony for its new nylon polymer facility, a milestone that represents the site’s transformation to a global nylon 6,6 production facility. © Invista

Article

The State of the US Specialty Chemicals Industry
Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

From Catalogue to Collaboration

Enamine's Expert Insights Collection Is Free to Download
Enamine’s 35 Years of Advancing Drug Discovery

Enamine's Expert Insights Collection Is Free to Download

From catalogue to collaboration — explore 35 years of drug discovery breakthroughs, novel building blocks, and the science shaping tomorrow's medicines. Download your complimentary copy now.

most read